LL 255 (Oscimin hyoscyamine sulfate extended release 0.375 mg)
Generic Name: hyoscyamine
Pill imprint LL 255 has been identified as Oscimin hyoscyamine sulfate extended release 0.375 mg.
Oscimin is used in the treatment of irritable bowel syndrome; crohn's disease; anesthesia; urinary incontinence; endoscopy or radiology premedication and belongs to the drug class anticholinergics/antispasmodics. Risk cannot be ruled out during pregnancy. Oscimin hyoscyamine sulfate extended release 0.375 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LL 255
- hyoscyamine sulfate extended release 0.375 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Larken Laboratories Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ethylcellulose (10 mPa.s)
D&C Yellow No. 10
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about Oscimin (hyoscyamine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- 0 Reviews – Add your own review/rating
- Drug class: anticholinergics/antispasmodics
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.